About this trial
This study aims to explore the effect of burst-taVNS (electric stimulation of the concha cymba) on tonic (capsaicin-induced skin pain) and acute (pressure pain sensitivity) experimental pain and cardioception. Primary outcomes include pain intensity. Secondary outcomes include sensory thresholds, resting heart rate (EKG), pupillary measurements and conditioned pain modulation.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Healthy
Speak and understand English
18-60 years old.
Disqualifiers
Pregnant and/or breastfeeding
Regular use of cannabis, opioids or other drugs
Current or previous neurologic, musculoskeletal, mental, or other illnesses (e.g., brain or spinal cord injuries, degenerative neurological disorders, major depression, cardiovascular disease, chronic lung disease, etc.)
Current regular (once or more a week) use of analgesic medication or other medication which may affect the trial (including paracetamol and NSAIDs)
Trial design
Crossover
Treatments tested in this trial
taVNS
DeviceTwo-headed ball-point electrode which is placed in the concha cymba.
Earlobe Stimulation
DeviceCircular urface adhering electrodes will be attached to either facet of the earlobe.
Sham (No Treatment)
DeviceCircular surface adhesive electrodes will be placed on either facet of the earlobe. No current will pass through the electrodes.
Treatment groups
Trial outcomes
Primary outcomes
Pain Intensity
Capaisin is a topically administered tonic pain model. Stemming from its chilly-origin, pain induced ressembels heat/light burning sensation which increases within 20minute of application to the forearm, before it plateaus. Associated pain can be stopped immediately by applying ice/cold water. Participants will be asked to rate (using a scale from 0 denoting no pain, to 10 denoting maximal pain) the intensity of the pain in 5 min time intervals.
Secondary outcomes
Pressure Pain Detection Threshold
Using the computerized pressure pain algometer tool (Nocitech, Aalborg, Denmark), cuffs placed on the calves of participants wll inflate at a consistent rate. Participants are instructed to rate the pain experiences using a visual analogue scale (VAS) and to press a button when the pain becomes intolerable. The VAS ranges from 0 denoting no pain, to 10 denoting maximal pain. Pain detection, namely the kPa where the VAS is at 1cm, and the pain tolerance, namely the kPa when the deflation-button is pressed, will be acquired.
Conditioned Pain Modulation Effect
Using the computerized pressure pain algometer tool (Nocitech, Aalborg, Denmark), cuffs placed on the calves of participants wll inflate at a consistent rate. Whilst participants have a constant pressure applied to their non-dominant leg, they are instructed to rate the pain experienced on the dominant leg as the cuff slowly inflates using a visual analogue scale (VAS) and to press a button when the pain becomes intolerable. The VAS ranges from 0 denoting no pain, to 10 denoting maximal pain. Conditioned pain detection, namely the kPa where the VAS is at 1cm, will be acquired.
Pressure Pain Perception
Trapezius pressure pain perception will be acquired using a handheld pressure algometer (Somedic, Solna, Sweden). Perpendicular to the musle and halfway between the acrominion and the processus spinous vertebrae, the 1cm2 probe will be applied at a constant rate. When particpants first feel pressure pain, they will respond with a button-press.
Pupillary Light Reflex
Using the Neurolight, per pupil, a 3s light reflex will be acquired. This refers to the reflex following the exposure to a light flash.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.